World Journal of Pharmacology and Toxicology
Open Access

Potential Exists to Develop Pharmacological Treatments that Target Particular Receptors

Okada Tetsuji^*

Department of Science, Kyoto University, Kyoto, Japan

Received Date: Jul 22, 2022 / Published Date: Oct 12, 2022

Citation: Tetsuji O (2022) Potential Exists to Develop Pharmacological Treatments that Target Particular Receptors. World J Pharmacol Toxicol 5:164

Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156

Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 2022 Tetsuji O. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF | Peer-reviewed Full Article

The discovery that no longer all agonists uniformly spark off cell signaling pathways (biased signaling) has noticeably modified the drug discovery procedure for agonists and the method for cure of sickness with agonists. Technological advances have enabled complicated receptor behaviors to be considered independently and via these assays, the bias for an agonist can be quantified. It is expected that therapeutic phenotypes will be linked, thru translational studies, to quantified scales of bias to information medicinal chemists in the drug discovery process.

Keywords